Abstract:Background: Coronavirus disease-2019 (COVID-19) epidemic is spreading globally. Sex differences in the severity and mortality of COVID-19 emerged. This study aims to describe the impact of sex on outcomes in COVOD-19 with a special focus on the effect of estrogen. Methods: We performed a retrospective cohort study which included 413 patients (230 males and 183 females) with COVID-19 from three designated hospitals in China with a follow up time from January 31, 2020, to April 17, 2020. Women over 55 were considered as postmenopausal patients according to the previous epidemiological data from China. The interaction between age and sex on in-hospital mortality was determined through Cox regression analysis. In addition, multivariate Cox regression models were performed to explore risk factors associated with in-hospital mortality of COVID-19. Results: Age and sex had significant interaction for the in-hospital mortality ( P < 0.001). Multivariate Cox regression showed that age (HR 1.041, 95% CI 1.009–1.073, P = 0.012), male sex (HR 2.033, 95% CI 1.007–2.098, P = 0.010), the interaction between age and sex (HR 1.118, 95% CI 1.003–1.232, P = 0.018), and comorbidities (HR 9.845, 95% CI 2.280–42.520, P = 0.002) were independently associated with in-hospital mortality of COVID-19 patients. In this multicentre study, female experienced a lower fatality for COVID-19 than male (4.4 vs. 10.0%, P = 0.031). Interestingly, stratification by age group revealed no difference in-hospital mortality was noted in women under 55 compared with women over 55 (3.8 vs. 5.2%, P = 0.144), as well as in women under 55 compared with the same age men (3.8 vs. 4.0%, P = 0.918). However, there was significantly difference in women over 55 with men of the same age group (5.2 vs. 21.0%, P = 0.007). Compared with male patients, female patients had higher lymphocyte ( P < 0.001) and high-density lipoprotein ( P < 0.001), lower high sensitive c reaction protein level ( P < 0.001), and lower incidence rate of acute cardiac injury (6.6 vs. 13.5%, P = 0.022). Conclusion: Male sex is an independent risk factor for COVID-19 in-hospital mortality. Although female mortality in COVID-19 is lower than male, it might not be directly related to the effect of estrogen. Further study is warranted to identify the sex difference in COVID-19 and mechanisms involved.

Sex Differences in Viral Entry Protein Expression and Host Transcript Responses to SARS-CoV-2

Sex Differences in Severity and Mortality Among Patients With COVID-19: Evidence from Pooled Literature Analysis and Insights from Integrated Bioinformatic Analysis

Sex differences in immune responses that underlie COVID-19 disease outcomes

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Sex-based clinical and immunological differences in COVID-19

COVID-19 and Sex Differences: Mechanisms and Biomarkers

Sex Differences in Patients with COVID-19: a Retrospective Cohort Study and Meta-Analysis

Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities

Individual Variation of the SARS‐CoV‐2 Receptor ACE2 Gene Expression and Regulation

Sex Differences in Clinical Findings among Patients with Coronavirus Disease 2019 (COVID-19) and Severe Condition

Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions

Sex Differences in Clinical Characteristics and Risk Factors for Mortality among Severe Patients with COVID-19: a Retrospective Study

Is COVID-19 Gender-sensitive?

Sex Differences on Clinical Characteristics, Severity, and Mortality in Adult Patients With COVID-19: A Multicentre Retrospective Study

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality

Comparisons of the Immunological Landscape of COVID-19 Patients Based on Sex and Disease Severity by Multi-Omics Analysis.

Aromatase, testosterone, TMPRSS2: determinants of COVID-19 severity

Sex differences in ACE2, TMPRSS2, and HLA-DQA2 expression in gray matter: Implications for post-COVID-19 neurological symptoms

Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes

Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies

Considering how biological sex impacts immune responses and COVID-19 outcomes